Chinese Journal of Cancerindexed by SCI
《癌症》杂志
BMC

[ Special series on Colorectal Cancer ]
doi: 10.1186/s40880-015-0033-7
Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
Wei-Gen Zeng, Jian-Wei Liang, Zheng Wang, Xing-Mao Zhang, Jun-Jie Hu, Hui-Rong Hou, Hai-Tao Zhou and Zhi-Xiang Zhou
Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, P.R. China
[Abstract]

Introduction
Preoperative chemoradiotherapy (CRT), followed by total mesorectal excision, has become the standard of care for patients with clinical stages II and III rectal cancer. Patients with pathologic complete response (pCR) to preoperative CRT have been reported to have better outcomes than those without pCR. However, the factors that predict the response to neoadjuvant CRT have not been well defined. In this study, we aimed to investigate the impact of clinical parameters on the development of pCR after neoadjuvant chemoradiation for rectal cancer.
Methods
A total of 323 consecutive patients from a single institution who had clinical stage II or III rectal cancer and underwent a long-course neoadjuvant CRT, followed by curative surgery, between 2005 and 2013 were included. Patients were divided into two groups according to their responses to neoadjuvant therapy: the pCR and non-pCR groups. The clinical parameters were analyzed by univariate and multivariate analyses, with pCR as the dependent variable.
Results
Of the 323 patients, 75 (23.2%) achieved pCR. The two groups were comparable in terms of age, sex, body mass index, tumor stage, tumor location, tumor differentiation, radiation dose, and chemotherapy regimen. On multivariate analysis, a pretreatment carcinoembryonic antigen (CEA) level of ≤5 ng/mL [odds ratio (OR) = 2.170, 95% confidence interval (CI) = 1.195–3.939, P = 0.011] and an interval of >7 weeks between the completion of chemoradiation and surgical resection (OR = 2.588, 95% CI = 1.484–4.512, P = 0.001) were significantly associated with an increased rate of pCR.
Conclusions
The pretreatment CEA level and neoadjuvant chemoradiotherapy-surgery interval were independent clinical predictors for achieving pCR. These results may help clinicians predict the prognosis of patients and develop adaptive treatment strategies.
Chinese Journal of Cancer 2015, Volume: 34, Issue 10
[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)

[Google Scholar]


[ More articles of the special series on Colorectal Cancer ]


Cite this article

Wei-Gen Zeng, Jian-Wei Liang, Zheng Wang, Xing-Mao Zhang, Jun-Jie Hu, Hui-Rong Hou, Hai-Tao Zhou and Zhi-Xiang Zhou. Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Chin J Cancer. 2015, 34:41. doi:10.1186/s40880-015-0033-7


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China